HBI 2022

Blog

In conversation with Stéphane Pichon, founding managing partner, Your Care Consult

Ahead of HBI 2022 next month, HBI caught up with Stéphane Pichon, founding managing partner, Your Care Consult and the chair of the Investing in Healthcare Property session on June 21, to find out how the healthcare property market fared last year, and prospects for the future. Pichon is joined by Steve Nitschke, managing director …

In conversation with Stéphane Pichon, founding managing partner, Your Care Consult Read More »

Partnering with university hospitals and research centres

These elite organisations are the spearhead for medical research in Europe and the rich Middle East. They are also the places where complex conditions are diagnosed and treated. Increasingly, they are also viewed by nation-states and the EU as the key to valuable world markets in medtech and pharma. And the direction of travel is clear. They …

Partnering with university hospitals and research centres Read More »

Subscription Healthcare: Seizing the Opportunity, HBI 2022

This new Seizing the Opportunity blog series unpackages the main topics at Healthcare Business International 2022 (June 20-22), the in-person CEO level event focused on for-profit healthcare. We’ll be uncovering the question; ‘What are the things you can do now to grow value?’. Almost every healthcare operator wants to move from delivering episodes of care …

Subscription Healthcare: Seizing the Opportunity, HBI 2022 Read More »

Benard Bensaid

New homecare to hospital platform launches in France

A major French operator, the Doctegestio group, has launched a new platform called Avec, which combines everything from dentistry and primary care to hospital and nursing homes. We talk to Bernard Bensaid, the entrepreneur behind Avec. Doctegestio has merged its care and healthcare platforms – Anapa and Doctocare – to create a single platform called …

New homecare to hospital platform launches in France Read More »

2022: Reason for optimism

In many ways, 2021 appears at first glance to have been a false dawn. Far from being put to the sword by vaccines, Covid is still very much with us and still the topic on everyone’s lips, and rightly so. And yet there remain reasons for optimism in the market. The HBI Pipeline enables HBI …

2022: Reason for optimism Read More »